IDXX · Company research
Idexx Laboratories Inc (IDXX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
22records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar | The article highlights two medical stocks with positive Earnings Surprise Prediction (ESP) metrics that could potentially beat their upcoming earnings reports. Idexx Laboratories (IDXX) holds a #2 Buy rating with a +0.59% ESP ahead of its November 2, 2026 earnings release, while Iovance Biotherapeutics (IOVA) has a #3 Hold rating with a +22.22% ESP before reporting on November 5, 2026. Both stocks show promise for positive earnings surprises based on the Zacks ESP methodology. | View source ↗ | Zacks Investment Research | Oct 20, 2026 | bullish | 1 | 1 |
| Idexx (IDXX) Moves to Buy: Rationale Behind the Upgrade | Idexx Laboratories (IDXX) has been upgraded to a Zacks Rank #2 (Buy) rating due to upward trends in earnings estimates. The upgrade reflects improved earnings outlook that could drive buying pressure and stock price increases. Analysts have steadily raised estimates for the company over the past three months, with a 0.8% increase in the Zacks Consensus Estimate. | View source ↗ | Zacks Investment Research | Oct 19, 2026 | bullish | 1 | 1 |
| IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance Australia | IDEXX Laboratories, Inc. (IDXX) Stock forecasts Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 15, 2026 | neutral | 0 | 0.6 |
| IDEXX Laboratories Inc (IDXX) Shares Surge 3.4% -- What GF Score of 96 Tells Investors - GuruFocus | IDEXX Laboratories Inc (IDXX) Shares Surge 3.4% -- What GF Score of 96 Tells Investors GuruFocus | View source ↗ | GuruFocus | Oct 15, 2026 | neutral | 0 | 0.6 |
| IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance | IDEXX Laboratories, Inc. (IDXX) Stock Forecasts Yahoo Finance | View source ↗ | Yahoo Finance | Oct 14, 2026 | neutral | 0 | 0.6 |
| IDEXX Laboratories, Inc. (IDXX) Stock Price, News, Quote & History - Yahoo! Finance Canada | IDEXX Laboratories, Inc. (IDXX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 14, 2026 | neutral | 0 | 0.6 |
| IDEXX Laboratories (IDXX) Stock May Be 12% Undervalued Despite AI Acquisition - Simply Wall Street | IDEXX Laboratories (IDXX) Stock May Be 12% Undervalued Despite AI Acquisition Simply Wall Street | View source ↗ | Simply Wall Street | Oct 14, 2026 | neutral | 0 | 0.6 |
| IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada | IDEXX Laboratories, Inc. (IDXX) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 11, 2026 | neutral | 0 | 0.6 |
| IDEXX Laboratories (NasdaqGS:IDXX) Stock Forecast & Analyst Predictions - Simply Wall Street | IDEXX Laboratories (NasdaqGS:IDXX) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 11, 2026 | neutral | 0 | 0.6 |
| IDEXX's results call is set for 8:30 a.m. ET on Nov. 2 - Stock Titan | IDEXX's results call is set for 8:30 a.m. ET on Nov. 2 Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| An AI tool that helps veterinarians document care is now owned by IDEXX. - Stock Titan | An AI tool that helps veterinarians document care is now owned by IDEXX. Stock Titan | View source ↗ | Stock Titan | Sep 30, 2026 | neutral | 0 | 0.6 |
| Should You Continue to Hold IDXX Stock in Your Portfolio? - Zacks Investment Research | Should You Continue to Hold IDXX Stock in Your Portfolio? Zacks Investment Research | View source ↗ | Zacks Investment Research | Sep 23, 2026 | neutral | 0 | 0.6 |
| Should You Continue to Hold IDXX Stock in Your Portfolio? - Yahoo Finance | Should You Continue to Hold IDXX Stock in Your Portfolio? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 23, 2026 | neutral | 0 | 0.6 |
| IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide - Yahoo Finance | IDEXX (IDXX) Stock Trades Below Fair Value Following Its 26% Slide Yahoo Finance | View source ↗ | Yahoo Finance | Sep 17, 2026 | neutral | 0 | 0.6 |
| IDEXX's CEO and CFO will take part in a Sept. 14 healthcare chat - Stock Titan | IDEXX's CEO and CFO will take part in a Sept. 14 healthcare chat Stock Titan | View source ↗ | Stock Titan | Aug 31, 2026 | neutral | 0 | 0.6 |
| Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? - Yahoo Finance | Are Wall Street Analysts Predicting IDEXX Laboratories Stock Will Climb or Sink? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 26, 2026 | neutral | 0 | 0.6 |
| Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - Yahoo Finance | Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? Yahoo Finance | View source ↗ | Yahoo Finance | Aug 21, 2026 | neutral | 0 | 0.6 |
| IDXX Stock Price and Chart — NASDAQ:IDXX - TradingView | IDXX Stock Price and Chart — NASDAQ:IDXX TradingView | View source ↗ | TradingView | Aug 15, 2026 | neutral | 0 | 0.6 |
| IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings - Simply Wall Street | IDEXX (IDXX) Stock Looks Fair On Cash Flow But Rich On Earnings Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Why IDEXX Laboratories (IDXX) Stock Is Down Today - Quiver Quantitative | Why IDEXX Laboratories (IDXX) Stock Is Down Today Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 14, 2026 | neutral | 0 | 0.6 |
| Why IDEXX Laboratories Stock Looks Undervalued After Raising Its 2026 EPS Outlook to $15 - TIKR.com | Why IDEXX Laboratories Stock Looks Undervalued After Raising Its 2026 EPS Outlook to $15 TIKR.com | View source ↗ | TIKR.com | Jun 25, 2026 | neutral | 0 | 0.6 |
| Here’s Why IDEXX Laboratories Stock Could Deliver Around 11% Annual Returns Despite a 15% YTD Pullback - TIKR.com | Here’s Why IDEXX Laboratories Stock Could Deliver Around 11% Annual Returns Despite a 15% YTD Pullback TIKR.com | View source ↗ | TIKR.com | May 8, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.